AI Visibility Scorecard
rcttrial.com · Healthcare
At 2.62/10, Novartis United States of America is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Backlinks, Domain Trust and News Mentions. That is fixable, and the signals below show where to start.
AI engines read this profile 1 times
Claude
Top 5% in Healthcare for AI visibility
20
AI Naming Predictability
iRarely named · 20/100
Healthcare average 11
Top 19% of Healthcare
See what's behind this score →2.62
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →30
Muse Index Score
iAI agent readiness
Agent-ready · 30/100
Healthcare average 18
See what's behind this score →0
from our crawl and measurement
Novartis United States of America describes itself simply: "News News archive Statements Stories Contacts News Check out our media hub for the latest news, stories, and updates from across our business." When AI engines look at it, they find little to work with. It scores 2.62 out of 10.
Our crawl found structured data on the page (ImageObject, Organization, WebPage) and a readable heading structure. It is missing an llms.txt file and a sitemap.
Strong · Good · Fair · Weak
Structured Data
Good
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Good
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 2.62/10, Novartis United States of America is near-invisible to AI engines today. That is fixable, and the signals above are where to start.
How is the investigational drug thought to work?
In the early stages of tendinopathy, levels of a protein called IL-17A increase in the affected tissue. IL-17A has a role in the immune system in fighting off infection, but it also plays a role in inflammation that can contribute to the development of RCT. The investigational drug is an IL-17A inhibitor, which means it aims to reduce levels of IL-17A in the body.
How will each participant’s health be monitored?
During this trial, participants will visit a clinic approximately 10 to 12 times.
What is a clinical trial?
Every year, hundreds of thousands of people take part in clinical trials (also known as clinical studies). These are carefully controlled scientific investigations that help us improve medicine all around the world.
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for Novartis United States of America.
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/rcttrial
Cite this score: Engagemii (2026). "AEO Score for Novartis United States of America." Retrieved from https://engagemii.com/aeo/brands/rcttrial
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform